Varinos Inc.

Varinos Inc. is a genomic solutions startup with a mission to empower families with precision medicine. Founded in 2017 and based in Japan, the company specializes in advanced clinical tests within the fields of reproductive medicine, obstetrics/gynecology, cancer, and neonatal genetic diseases. One of their key offerings is the "Endometrial Microbiome Testing," which leverages cutting-edge genome technology to detect trace amounts of bacteria with high sensitivity. Additionally, they provide "preimplantation genetic testing" to examine embryo genes and chromosomes for abnormalities before conception. In August 2022, Varinos Inc. secured a Series C investment round with Fast Track Initiative, Inc. lining up as the lead investor. With a focus on pioneering genomic tests for the era of genomic medicine, where diagnoses are based on genome diversity, Varinos Inc. continues to push the boundaries of healthcare innovation, offering personalized genomic solutions that could revolutionize the future of medicine.